Trials / Completed
CompletedNCT02325271
Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers
Intra-individual Variability and Circadian Rhythm of Systemic Vascular Endothelial Growth Factor (VEGF) Levels and Interaction With Biomarkers of Inflammation in Subjects With Normal Glucose Tolerance (NGT) and Patients With Type 2 Diabetes Without Diabetic Macular Edema (DME)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- GWT-TUD GmbH · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study evaluates the intra-individual variability of VEGF levels over a period of 6 months as well as the circadian variation of VEGF levels, both under standardized conditions in patients with type 2 diabetes without DME and matched subjects with normal glucose tolerance (NGT). Secondary objectives of the study are to evaluate the relationship of individual VEGF-levels to biomarkers of inflammation, HbA1c and major cardiovascular risk factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Frequent blood and urine sampling and blood pressure measurement | Blood and urine sampling for the determination of VEGF and biomarkers |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-10-01
- Completion
- 2016-01-01
- First posted
- 2014-12-24
- Last updated
- 2017-09-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02325271. Inclusion in this directory is not an endorsement.